Dexcom (DXCM) Shares Repurchased (2023 - 2025)

Dexcom (DXCM) has 3 years of Shares Repurchased data on file, last reported at $312.8 million in Q4 2025.

• Shares Repurchased for Q4 2025 came in at $312.8 million, changed N/A year-over-year; the trailing twelve-month figure through Dec 2025 was $1.2 billion (changed 0.0% YoY), and the FY2025 annual result was $500.0 million, down 33.33% from the prior year.
• Shares Repurchased grew to $312.8 million in Q4 2025 per DXCM's latest filing, from $187.2 million in the prior quarter.
• Over five years, Shares Repurchased peaked at $750.0 million in Q3 2024 and troughed at $187.2 million in Q3 2025.
• A 3-year average of $437.5 million and a median of $406.4 million in 2023 frame the typical range for Shares Repurchased.
• On a YoY basis, Shares Repurchased climbed as much as 75.04% in 2025 and fell as far as 75.04% in 2025.
• A 3-year view of Shares Repurchased shows it stood at $500.0 million in 2023, then soared by 50.0% to $750.0 million in 2024, then slumped by 58.29% to $312.8 million in 2025.
• Business Quant data shows DXCM's Shares Repurchased at $312.8 million in Q4 2025, $187.2 million in Q3 2025, and $750.0 million in Q3 2024.